Tech Transfer eNews Blog
University-Industry Engagement Advisor

UCB acquires Duke gene therapy start-up for up to $30M

By Jesse Schwartz
Published: April 11th, 2018

Belgium-based biopharma giant UCB has acquired a Duke University start-up for up to $30 million.

Founded in 2015, Element Genomics is focused on developing genome-editing technologies in order to “pinpoint the right point of intervention for a therapeutic,” says Roger Palframan, head of external innovation at UCB.

“UCB is constantly assessing the capabilities we need to have the highest impact,” says Palframan. Given the “strong interaction we have had with Duke University on various different programs in UCB,” the team and technology at Element Genomics fit well with that strategy, he adds.

The roughly $30 million acquisition includes upfront and milestone payments. Element Genomics will remain based in downtown Durham, NC, where it will stay in close collaboration with Duke.

Source: Triangle Business Journal

Posted under: Tech Transfer e-News

Twitter Facebook Linkedin Pinterest Email

No Comments so far ↓

There are no comments yet...Kick things off by filling out the form below.

Leave a Comment